Previous close | 1.4800 |
Open | 1.4500 |
Bid | 1.4900 x 500 |
Ask | 1.5200 x 400 |
Day's range | 1.4300 - 1.5950 |
52-week range | 0.6170 - 4.8700 |
Volume | |
Avg. volume | 1,770,411 |
Market cap | 173.751M |
Beta (5Y monthly) | 0.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) on March 1, 2024, according to a recent SEC Filing.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.29. FDS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
Q4 2023 Karyopharm Therapeutics Inc Earnings Call